Fractyl Health (GUTS) Net Cash Flow (2023 - 2026)

Fractyl Health (GUTS) has 4 years of Net Cash Flow data on file, last reported at -$18.4 million in Q1 2026.

• For the quarter ending Q1 2026, Net Cash Flow rose 27.54% year-over-year to -$18.4 million; the trailing twelve-month figure through Mar 2026 stood at $21.1 million (up 126.44% YoY), and the FY2025 full-year result was $14.1 million, down 58.53% from the prior year.
• Net Cash Flow for Q1 2026 stood at -$18.4 million, down from $3.9 million in the prior quarter.
• Across five years, Net Cash Flow topped out at $88.2 million in Q1 2024 and bottomed at -$25.4 million in Q1 2025.
• A 4-year average of $1.1 million and a median of -$11.7 million in 2023 frame the typical range for Net Cash Flow.
• Peak annual rise in Net Cash Flow reached 1021.77% in 2024, while the deepest fall reached 207.67% in 2024.
• Tracing GUTS's Net Cash Flow over 4 years: stood at -$11.3 million in 2023, then slumped by 52.33% to -$17.2 million in 2024, then surged by 122.58% to $3.9 million in 2025, then sank by 573.14% to -$18.4 million in 2026.
• According to Business Quant data, Net Cash Flow over the past three periods registered -$18.4 million, $3.9 million, and $55.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison